EE504 Cost-Effectiveness Analysis of Tremelimumab As First-Line Therapy for Metastatic Non-Small Cell Lung Cancer in Japan
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.2268
https://www.valueinhealthjournal.com/article/S1098-3015(24)02482-3/fulltext
Title :
EE504 Cost-Effectiveness Analysis of Tremelimumab As First-Line Therapy for Metastatic Non-Small Cell Lung Cancer in Japan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02482-3&doi=10.1016/j.jval.2024.03.2268
First page :
Section Title :
Open access? :
No
Section Order :
10263